Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedReleaf Australia
Brisbane, Queensland, Australia
- Ownership
- Private
- Development stage
- Other
01
Overview
MedReleaf Australia is a leading Australian medical cannabis company, now a wholly owned subsidiary of Aurora Cannabis. It specializes in the cultivation, importation, warehousing, and manufacturing of pharmaceutical-grade cannabis products, serving clinicians and patients across Australia. The company is recognized for its role in research, product development, and clinician education, aiming to improve health outcomes for patients using medical cannabis[1][2][3].
- Therapeutic areas
- OncologyNeurologyOther
- Modalities
- Cannabis extractCannabis oilDried cannabis flowerCannabis pastille
- Industry
- Biotech
02
Partnerships
Aurora Cannabis Enterprises
Beyond the preview
Go deeper on MedReleaf Australia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MedReleaf Australia.